Trial
NCT02606214
A Multiple Ascending Dose Study With a Dose Formulation Comparison Cohort to Evaluate the Safety, Tolerability, and Pharmacokinetics of TBA-354 in Healthy Adult Subjects
Phase ITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Global Alliance for TB Drug Development
Collaborators
—
Condition
Tuberculosis
Intervention
TBA-354
Why stopped
Clinical Hold from FDA
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-09-18